(PTH) Invesco DWA Healthcare - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46137V8524 • Health
PTH: Healthcare, Pharmaceuticals, Biotechnology, Medical, Devices, Equipment
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of at least 30 securities of companies in the healthcare sector that have powerful relative strength or momentum characteristics. ‣ Company URL: http://www.invesco.com/us ‣ Domicile: United States
Additional Sources for PTH ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PTH ETF Overview
| Market Cap in USD | 122m |
| Category | Health |
| TER | 0.60% |
| IPO / Inception | 2006-10-12 |
PTH ETF Ratings
| Growth 5y | 10.9% |
| Fundamental | - |
| Dividend | 5.51% |
| Rel. Strength Industry | -78.7 |
| Analysts | - |
| Fair Price Momentum | 37.14 USD |
| Fair Price DCF | - |
PTH Dividends
| Dividend Yield 12m | 0.06% |
| Yield on Cost 5y | 0.08% |
| Annual Growth 5y | % |
| Payout Consistency | 14.2% |
PTH Growth Ratios
| Growth Correlation 3m | -88.7% |
| Growth Correlation 12m | 24.1% |
| Growth Correlation 5y | -18.9% |
| CAGR 5y | 6.22% |
| CAGR/Mean DD 5y | 0.25 |
| Sharpe Ratio 12m | 0.18 |
| Alpha | -20.84 |
| Beta | 1.01 |
| Volatility | 25.16% |
| Current Volume | 18.1k |
| Average Volume 20d | 9.6k |
What is the price of PTH stocks?
As of January 23, 2025, the stock is trading at USD 41.58 with a total of 18,100 shares traded.
Over the past week, the price has changed by +3.41%, over one month by +1.96%, over three months by -10.50% and over the past year by +5.70%.
As of January 23, 2025, the stock is trading at USD 41.58 with a total of 18,100 shares traded.
Over the past week, the price has changed by +3.41%, over one month by +1.96%, over three months by -10.50% and over the past year by +5.70%.
Is Invesco DWA Healthcare a good stock to buy?
Neither. Based on ValueRay Analyses, Invesco DWA Healthcare is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 10.85 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PTH as of January 2025 is 37.14. This means that PTH is currently overvalued and has a potential downside of -10.68%.
Neither. Based on ValueRay Analyses, Invesco DWA Healthcare is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 10.85 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PTH as of January 2025 is 37.14. This means that PTH is currently overvalued and has a potential downside of -10.68%.
Is PTH a buy, sell or hold?
Invesco DWA Healthcare has no consensus analysts rating.
Invesco DWA Healthcare has no consensus analysts rating.
What are the forecast for PTH stock price target?
According to ValueRays Forecast Model, PTH Invesco DWA Healthcare will be worth about 41.3 in January 2026. The stock is currently trading at 41.58. This means that the stock has a potential downside of -0.65%.
According to ValueRays Forecast Model, PTH Invesco DWA Healthcare will be worth about 41.3 in January 2026. The stock is currently trading at 41.58. This means that the stock has a potential downside of -0.65%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 41.3 | -0.6% |